AU7692594A - Macrolides as antagonists of macrophilin binding immunosuppressants - Google Patents

Macrolides as antagonists of macrophilin binding immunosuppressants

Info

Publication number
AU7692594A
AU7692594A AU76925/94A AU7692594A AU7692594A AU 7692594 A AU7692594 A AU 7692594A AU 76925/94 A AU76925/94 A AU 76925/94A AU 7692594 A AU7692594 A AU 7692594A AU 7692594 A AU7692594 A AU 7692594A
Authority
AU
Australia
Prior art keywords
macrolides
antagonists
macrophilin binding
immunosuppressants
binding immunosuppressants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU76925/94A
Inventor
Theodor Fehr
Jean-Jacques Sanglier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of AU7692594A publication Critical patent/AU7692594A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/29—Micromonospora

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU76925/94A 1993-09-01 1994-08-31 Macrolides as antagonists of macrophilin binding immunosuppressants Abandoned AU7692594A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9318144 1993-09-01
GB939318144A GB9318144D0 (en) 1993-09-01 1993-09-01 Organic compounds
PCT/EP1994/002894 WO1995006649A1 (en) 1993-09-01 1994-08-31 Macrolides as antagonists of macrophilin binding immunosuppressants

Publications (1)

Publication Number Publication Date
AU7692594A true AU7692594A (en) 1995-03-22

Family

ID=10741346

Family Applications (1)

Application Number Title Priority Date Filing Date
AU76925/94A Abandoned AU7692594A (en) 1993-09-01 1994-08-31 Macrolides as antagonists of macrophilin binding immunosuppressants

Country Status (3)

Country Link
AU (1) AU7692594A (en)
GB (1) GB9318144D0 (en)
WO (1) WO1995006649A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6124453A (en) * 1995-07-04 2000-09-26 Novartis Ag Macrolides
AR006514A1 (en) * 1995-07-04 1999-09-08 Sandoz Ag A MACROLID, ITS USES, A PROCESS TO PRODUCE IT, A BIOLOGICALLY PURE ISOLATE CAPABLE OF PRODUCING IT, AND A PHARMACEUTICAL COMPOSITION THAT IT INCLUDES
US5912224A (en) * 1996-02-22 1999-06-15 The General Hospital Corporation Methods and compositions for enhancing cellular response to TGF-β ligands
US20030119797A1 (en) * 2001-05-09 2003-06-26 Salah-Dine Chibout Methods for selective immunomodulation
US7186518B2 (en) * 2003-11-21 2007-03-06 Dade Behring Inc. Method and composition useful for determining FK 506
JP2009529049A (en) 2006-03-07 2009-08-13 ワイス Meridamycin analogs for the treatment of neurological disorders
GB201122305D0 (en) 2011-12-23 2012-02-01 Biotica Tech Ltd Novel compound
US20200131196A1 (en) 2017-02-10 2020-04-30 Mount Tam Therapeutics, Inc. Rapamycin Analog

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4843008A (en) * 1984-12-24 1989-06-27 Yamanouchi Pharmaceutical Co., Ltd. Novel microorganisms and a novel process for producing antibiotics

Also Published As

Publication number Publication date
WO1995006649A1 (en) 1995-03-09
GB9318144D0 (en) 1993-10-20

Similar Documents

Publication Publication Date Title
AU686583B2 (en) Introducer sheath
AU7626496A (en) Heteroaryl compounds
AU6374896A (en) Cable-sheathing composition
AU6231894A (en) Waterproof oversock
AU7159994A (en) 3-aryl-4-hydroxy-delta3-dihydrofuranone derivatives
AU5794094A (en) Tricritical point composition
AU5060796A (en) Composition
AU2468392A (en) Novel immunosuppressants
AU691230B2 (en) Bit synchronizer
AU4931693A (en) Ibuprofen-h2 antagonist combinations
AU5261093A (en) Aminoalkylphenyl compounds
AU5560596A (en) Formed compositions
AU7437094A (en) Disinfectant-detergent composition
AU6571594A (en) Thioindole pyperidinyl derivatives used as antalgics
AU7692594A (en) Macrolides as antagonists of macrophilin binding immunosuppressants
AU5773994A (en) Cable-making compositions
AU1093495A (en) Self-foaming multifunctional cleansing composition
AU4023197A (en) Biodegradation of explosives
AU672124B2 (en) Composition
AU1129697A (en) Modified polyalkadiene-containing compositions
AU1119895A (en) External preparation
AU6619596A (en) Compositions
AU7702996A (en) Solid composition
AU3709593A (en) N-methyldeacetylcolchiceinamide derivatives
ZA948591B (en) 6-oxo-nucleosides useful as immunosuppressants